← Leaderboards
Allison M. Martin
Albert Einstein College Of Medicine
$972,920
Attributed
$972,920
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $195.2K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$972,920 · 1
By mechanism
K08$972,920 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Xingxing Zang$11,384,072
- Hayley M. McDaid$2,455,489
- Bhaskar Chandra Das$3,457,971
- Anjali Sharma$19,812,193
- Vanessa Ruiz$160,284
Others in their field
Other Emerging Leaders on “Color”
- Scott Topper · Broad Institute, Inc.$153,718,762
- Alicia Yiran Zhou · Color Health, Inc.$25,320,209
- Mark Brian Reed · San Diego State University$13,471,024
- Robert A Kaindl · Arizona State University$13,377,213
- Gabriel Nestor Sanchez · Enspectra Health, Inc.$8,239,040
- Giacomo Vacca · Kinetic River Corporation$5,262,077
Research focus
ColorAnimal ModelCollegeC-Myc GenesBioinformaticsBiostatistical MethodsBlocking AntibodiesChildhood Brain NeoplasmChildhood Malignant Brain TumorClinical TrialsBone MarrowCancer TherapyCareer DevelopmentCd276 GeneCell CycleCell Death InductionCellsAntibodiesAnti-Tumor Immune ResponseCharacteristicsCheckpoint TherapyChildChildhoodContralateral
Grant awards (5)
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets$195,184
K08 · FY2024 · NS · contact PI
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets$195,184
K08 · FY2023 · NS · contact PI
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets$194,184
K08 · FY2022 · NS · contact PI
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets$194,184
K08 · FY2021 · NS · contact PI
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets$194,184
K08 · FY2020 · NS · contact PI